Chronic kidney disease treated with hemodialysis Urological and Genital Diseases
Conditions
Interventions
Current interventions as of 16/03/2026:
This prospective, multicenter pre–post within-subjects study was conducted in 10 HD clinics across five Swedish regions. Clinics implemented the intervention ba
each clinic was considered a cluster.
Recognition and Correction of Volume Alterations (Recova®), a fluid management decision aid combining clinical assessments with bioimpedance spectroscopy (BIS),
Sponsors
Uppsala University
Eligibility
Sex/Gender
All
Age
18 Years to 120 Years
Inclusion criteria
Inclusion criteria: Patients over 18 years of age who had been treated with hemodialysis for more than three months
Exclusion criteria
Exclusion criteria: 1. Patients with critical illness 2. Expected survival less than 6 months 3. Inability to provide informed consent - due to language or cognitive insufficiency 4. Home-HD treatment 5. Pacemaker 6. Did not have a documented need for ultrafiltration
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fluid status and recovery time were measured using bioimpedance spectroscopy and patients answering, "How long does it take you to recover from dialysis?" at baseline and after 12 weeks exposure to the intervention. | — |
Secondary
| Measure | Time frame |
|---|---|
| Volume status scores were measured using Recova® every second week during the 12 weeks intervention period i.e. at six occasions. | — |
Countries
Sweden
Contacts
Public ContactJenny Stenberg
Outcome results
None listed